ocular emergencies and urgencies...• axial myopia (> -3 d increases the danger 10 fold) •...
TRANSCRIPT
3/29/2016
1
OCULAR URGENCIES AND
EMERGENCIESRosmary Sanchez O.D., M.B.A.
Common Urgencies and Emergencies
1. Trauma:1. Chemical burns
2. Open globe trauma
2. Infectious:1. Endophthalmitis
2. Orbital cellulitis
3. Neurological:1. Acute third nerve palsy (rule out intracranial aneurysm)
4. Glaucomatous:1. Angle closure glaucoma
5. Retinal:1. Macula on rhegmatogenous retinal detachment
6. Vascular:1. Central retinal artery occlusion2. Ischemic optic neuropathy
Case Presentation
• Splash of drano in right eye
about 15 min ago.
• Started washing eye since then
• Gross examination:
• Cornea: sloughing of epithelium,
edema
• Scattered limbal ischemia
• Why just a gross examination at
this point?
3/29/2016
2
Chemical Burns
• Range from mild epithelial defects to complete opacification and destruction of tissue
• Alkali injuries are typically more severe than acid injuries
• Incidence: 7.7 -18% of all ocular traumas
• > young males and > at work
• The severity of the a chemical injury depends on the chemical substance• pH• Volume
• Toxicity of the chemical (degree of penetration and cell injury)
• Duration of contact
Chemical Burns
• Alkali Burns
• Cause saponification of the fatty acids
in cell membrane.
• Subsequently, destruction of the
proteoglycan ground substance and
collagen fibers of the stromal matrix.
• Stronger alkali substances may
penetrate into the anterior chamber
in 15 minutes.
• Secondary conditions: glaucoma,
cataracts, and uveitis.
• Acid Burns
• Limited to superficial layers of the
cornea causing protein coagulation.
• Coagulated proteins can act as a
barrier to further acid penetration
• Hydrogen molecules damage the
ocular surface by altering the pH.
• Anions cause protein denaturation,
precipitation, and coagulation
http://www.reviewofoptometry.com/content/d/news_review/c/17150/dnnprintmode/tru
e/?skinsrc=[l]skins/ro2009/pageprint&containersrc=[l]containers/ro2009/simplehttp://www.oculist.net/downaton502/prof/ebook/duanes/graphics/figures/v4/0280/004f.jpg
Chemical Burns
• Classification
• Modified Hughes/Roper Hall
classification
• Based on the degree of corneal
involvement
• Limbal ischemia
• Dua classification
• Limbal involvement (in clock hours)
• Percentage of conjunctival involvement
3/29/2016
3
Chemical Burns
• Immediate Management:
• Copious irrigation with sterile isotonic solution
until pH is neutral.
• Tap water, although hypotonic, is an appropriate
substitute.
• Instill topical anesthetic (proparacaine or lidocaine
4%) to facilitate irrigation and relieve pain.
• Irrigate under eyelids to remove chemical
residue completely.
• In cases of acid burns, debridement of
devitalized corneal epithelium should be done.
Chemical Burns• Medical Management:
• Inflammation: Steroid
• Pred-Forte every 1hr or Durezol every 2hrs then taper
• Recommended only for the acute phase
• Usage should be guarded and followed closely
• Infection:
• Broad spectrum antibiotic
• Pain:
• Cycloplegics, lubrication (preferred ointments and PF)
• Collagenase inhibitors:
• Topical acetylcysteine 10% or 20% every 4 hours
• Tetracyclines such as Doxycycline 50 mg BID
• High dose of ascorbic acid ~2g/day
• Bandage contact lens
• Amniotic membrane
• Surgical therapy:• Limbal stem cell transplantation
• Corneal transplantation
Case Presentation
Presentation:
• 102F fever.
• Painful eye movement, OS
• MHx: Previous sinusitis infection
• Restricted ocular motility, OS
• BCVA: 20/20 OD; 20/50 OS
• Chemosis
• Proptosis
3/29/2016
4
Orbital Cellulitis
Life threatening infection of the orbital
soft tissues behind the orbital septum
Orbital Cellulitis
Pathogenesis:• Extension from periorbital structures
• Paranasal sinus
• Face and eyelids
• Lacrimal sac (dacryocystitis)
• Teeth (dental infection)
• Extension of pre-septal cellulitis
• Exogenous causes:
• Trauma - within 72 hours of injury that penetrates the septum
• Surgery
• Endogenous causes:
• Bacteremia with septic embolization
• Intraorbital causes:
• Endohthalmitis
• dacryoadenitis
• Sinusitis:• H. influenzae (children)
• S. pneumoniae
• S. aureus
• Other streptococci
• Moraxella catarhalis
• Anaerobic
• Post trauma/Post-surgical• S. aureus
• Anaerobic
Orbital Cellulitis
• Presentation:
• Fever (102 F or greater)
• Painful eye movement
• Restricted ocular motility
• Decrease in vision
• Proptosis/globe displacement
• Raised intraocular pressure
• Eyelid edema (absence of eyelid crease)
• Conjunctival chemosis
• Severe malaise and headache
3/29/2016
5
Orbital Cellulitis
Complications:
• Subperiosteal/orbital abscess
• ONH damage and blindness
• Cavernous sinus thrombosis
• Meningitis
• Septicemia (blood infection)
• Death
• Prognosis depends on the organism
and the extent of disease at the time of
presentation
Case Presentation
• 65 yo Asian female
• Ocular pain
• Blurred vision in one eye
• Halos around lights
• With nausea and one episode of vomiting
• Headache
• BCVA: 20/20 OD, 20/50 OS
• IOP: 20 mmHg/63mmHg
• Mid-dilated OS pupil
• Closed angles, OS; narrowed angle, OD
http://static1.squarespace.com/static/544d12ade4b07393756a3be5/54e2f1a0e4b09bab132a5b54/54
e2f1b3e4b09bab132a5b8b/1424249466687/ANGLE-CLOSURE-GLAUCOMA.png?format=500w
Acute Angle Closure Glaucoma
• Characterized by a rapid and large increase in the intraocular pressure (IOP), resulting from a sudden blockage of the trabecular meshwork by the iris.
Pathophysiology:
• Pupillary block• Excessive iris-lens apposition impedes the flow of
aqueous from PC to AC, elevating PC aqueous pressure
• Secondary forward bowing of peripheral iris results in occlusion of the TM
• Alternative mechanisms: Plateau iris, ciliary block.
3/29/2016
6
Acute Angle Closure Glaucoma
Risk Factors:
• Age > 40 yo (lens thickness, cataracts)
• Female gender (2x > male gender)
• Family history (first degree relatives)
• Hyperopic individuals
• Anterior chamber depth < 2.5mm
• Race: Inuit 5% > Asian 1.4% > White 0.6%
> Black 0.2%
• Certain medications e.g. Topamax
Acute Angle Closure Glaucoma
Acute Symptoms: Acute Signs:
• Ocular pain • Elevated IOP
• Blurred vision • Closed/narrow angle
• Haloes around lights • Corneal edema
• Nausea and vomiting • Conjunctival injection
• Headache (frontal or supraorbital)
• Mid dilated sluggish moving and irregularly shaped pupil
• Iris bombe (typically)
• Glaucomfecken and sectoral iris atrophy – indicators of previous episodes of AACG
• Optic nerve head damage
Acute Angle Closure Glaucoma
3/29/2016
7
Acute Angle Closure Glaucoma
Tests:
• Gonioscopy
• To examine the iridocorneal angle
• R/O other causes:
• Glaucomatocyclitic crisis, NV glaucoma, malignant glaucoma, angle mass, iridocorneal endothelial syndrome (ICE)
• Dynamic gonioscopy
• Reversible (appositional closure)
• Irreversible (synechial closure).
• A scan, ultrasound biomicroscopy, anterior
segment OCT
Acute Angle Closure Glaucoma
Treatment:
• Topical drops:
• Beta adrenergic antagonists
• Alpha2 adrenergic agonists
• CAI- topical and oral.
• Miotics 1-2% Pilocarpine after IOP starts to normalize
• Hyperosmotics
• Topical corticosteroids
• Globe compression and dynamic gonioscopy
Acute Angle Closure Glaucoma
Surgical Treatment:
• Laser peripheral iridotomy (LPI)
• If laser iridotomy cannot be performed:
• Surgical irdectomy
• Peripheral iris may be flattened with a laser iridoplasty
• Pupillary block may be relieved with a laser pupilloplasty.
The fellow eye shares the anatomic predisposition for
increased pupillary block.
• Recommended to do a peripheral iridotomy.
• 50% chance of developing an acute attack in the untreated fellow eye
within 5-10 years
3/29/2016
8
Case Presentation
Symptoms:
• Double vision (vertical and
horizontal)
• Severe ptosis, OD
• Ipsilateral frontal headache
• Dilated pupil, OD
• Down and out position, OD
Pupil Involving Third Nerve Palsy
Isolated CN3 palsy with pupil involvement should be considered an ophthalmic
and neurosurgical emergency (95-97% is caused by an aneurysm in PCA)
Pupil Involving Third Nerve Palsy
Imaging:
• Computed tomography angiography (CTA)
• Magnetic resonance angiography (MRA)
• Common catheter angiography (CCA)
Highly and equally sensitive in diagnosing of 95% of 3 mm intracranial aneurysm or larger
Early intervention can improve return of neural function and avoid a catastrophic rupture, which carries a significantly high rate of mortality
3/29/2016
9
• 54 yo female.
• Flashes of light and floaters since yesterday, OS
• Darkness over one half of visual field OS
• BCVA: 20/20 OD, OS
• Shaffer’s sign “tobacco dust” pigmented cells in
the vitreous
• And:
Case Presentation
Rhegmatogenous Retinal Detachment
• Full thickness retinal defect caused
by liquefied vitreous passing through
a retinal break into a potential
epithelioretinal interspace between
the sensory retina and the RPE.
• “rhegma” – break
• Most common retinal detachment
Rhegmatogenous Retinal Detachment
Risk Factors
• Posterior vitreous detachment
• Axial myopia (> -3 D increases the danger 10 fold)
• Surgery (Post cataract surgery or Yag laser capsulotomy)
• Lattice degeneration (Up to 30% of all RRD. )• The lifetime risk of RD in a patient with lattice is less than 1%.
• RD in one eye • Risk in 2nd eye is 5.8% (first year) and 10% within 4 years.
• Fam hx of RD
• Ocular trauma
• Genetic disorders: Marfans syndrome, sticklers syndrome
3/29/2016
10
Rhegmatogenous Retinal Detachment
• Small & peripheral:
• laser photocoagulation (or cryotherapy) around the break
• Takes 3 - 14 days for maximal retinal adhesion to be
achieved.
• Larger RRD:
• Vitrectomy
• Scleral buckle
• Pneumatic retinopexy
• CF6 or C3F8 “air/gas bubble” as a tamponade
• Silicon oil
Treatment depends upon the type and size of retinal
detachment:
Eye of a 72-yo woman shows normal yellowing of the
lens due to age-related nuclear sclerotic cataract
Same woman’s other eye shows a more severe
nuclear sclerotic cataract two years after vitrectomy.
Rhegmatogenous Retinal Detachment
Time frame for management:
• The status of the macula is the primary determinant of the emergency.
• If “Mac on” the repair should be performed within 24 hours.
• If “Mac-off” the repair is less critical and can be performed within 7 days.
Case Presentation
• 72 yo WM
• Sudden, severe, painless loss of
vision in right eye
• MHx: left carotid stent (3 weeks
ago)
• Meds: Plavix, Aspirin, Multivitamin
• BCVA:
• CF, OD
• 20/30, OS
• APD
3/29/2016
11
Central Retinal Artery Occlusion
Presentation:• Sudden, painless, monocular, severe loss of
vision.• May have had previous episodes of amaurosis fugax
• >50 years of age
• Vision acuity from 20/40 to CF
• Retinal appearance:• Opaque, edematous
• cherry red spot
• Narrowed retinal arterioles
• Pallor of ONH and sometimes disc edema.
• Later stages: optic nerve atrophy and neovascularization (controversial)
Central Retinal Artery Occlusion
• Etiology:
• Arterial emboli (cholesterol, fibro-platelet, calcific)
• Thrombotic
• Arteritis: GCA, polyarteritis nodosa.
• Hypercoagulation disorders, collagen vascular, and
inflammatory disorders such as lupus.
• Ocular conditions associated with retinal arterial
obstruction (ONH drusen)
Embolus is the most common cause of
CRAO, accounting for over 2/3 of all
cases. The carotid artery and the heart
are the most common sources.
Central Retinal Artery Occlusion
• Treatment:
• To dislodge the embolus:
• Ocular massage
• Artery dilation to up to 16% due to autoregulation
• Blood flow increase to up to 86%
• Then, lowering IOP
• Anterior chamber paracentesis
• IV acetazolamide
• Vasodilation (inhaling CO2)
• Intra-arterial thrombolysis
• Hyperbaric oxygen therapy
3/29/2016
12
Central Retinal Artery Occlusion
Systemic evaluation:
• Cardiovascular evaluation
• Hyperviscosity evaluation
• Hypercoaguable evaluation
• Hemoglobinopathies
Vascular work up Suggested
Exclude arteritic cause ESR, CRP, CBC, and platelet
Common vascular
risks factors
Blood pressure
Fasting cholesterol and profile
Fasting blood sugar level
Investigating for
embolic sources
Duplex carotid ultrasound
Echocardiogram
Young patients (<50yo)
w/ no vascular risk
factors
Vasculitic screen (ANA, ENA, ANCA,
ACE)
Hypercoagulable screens
(antiphospholipid antibody, factor V
Leiden, protein C&S)
Myeloproliferative or sickle cell disease
(blood film)
Homocysteine
Systemic and ocular conditions related to retinal artery occlusions:
Systemic cardiovascular disease
HTN, DM, atheromatous disease, cardiovalvular diasease, bacterial endocarditis, myoxoma, arrythmias.
Coagulopathies:
Antiphospholipid antibodies, Protein C deficiency, Protein S deficiency, Antithrombin III deficiency, Elevation of platelet factor 4, Sickle cell anemia, Homocysteine.
Systemic vasculitis:
Polyarteritis nodosa, temporal arteritis, Kawasaki's syndrome, Wegener's granulomatosis, Susac's disease, systemic lupus erythematosus
Oncologic:
Metastatic tumors, leukemia, lymphoma
Infective diasease:
Syphilis, HIV
Trauma:
Direct ocular compression, penetrating injury, retrobulbar injection, orbital trauma, Purtscher's disease
Ocular conditions:
Preretinal arterial loops, optic nerve drusen, necrotizing herpetic retinitis, toxoplasmosis
Other causes:
Oral contraceptives, pregnancy, drug abuse, migraine
Central Retinal Artery Occlusion
• The only true emergency would be if the patient comes within 97 min of the
event and to rule out giant cell arteritis in patients older than 50 years.
• If GCA: steroid therapy is recommended immediately and scheduled for temporal artery
biopsy.
• Otherwise, etiology evaluation is generally recommended as an outpatient basis.
• Time is tissue!!!
• Prognosis:
• Life expectancy: 5.5 years
3/29/2016
13
Case Presentation
• 78 yo WF
• Sudden and painless decrease in vision for 2 days, OD
• New onset of headaches for three days that gets worse
after combing hair
• Joint pain
• General malaise
• RAPD
• BCVA: 20/300 OD, 20/30 OS
• After DFE and HVF:
Arteritic Anterior Ischemic Optic Neuropathy
• Inflammatory and thrombotic involvement of the short posterior ciliary arteries (SPCA’s) with resultant optic nerve head occlusion and infarct of retina
• Caused by Giant cell arteritis (GCA)
• chronic medium and large sized arteries vasculitis that affect the superficial temporal arteries and ophthalmic arteries
• Approximately 0.5-27 cases per 100,000 people aged 70 years or older
• Incidence is higher for Caucasians and European descent
• Females 3x > males
Arteritic Anterior Ischemic Optic Neuropathy
Systemic presentation:
• Headaches • New onset headaches
• Most common systemic complaint
• Localized to the temporal side of the head
• Jaw claudication
• Scalp tenderness (combing hair)
• Night sweats
• Fever
• Arthralgia
• ≥ 60 yo• 90% of affected individuals >65 yo
3/29/2016
14
Arteritic Anterior Ischemic Optic Neuropathy
Ophthalmic presentation:
• Amaurosis fugax (30%)
• Visual field defect (commonly altitudinal)
• APD
• Pale swollen disc often with flame-shaped
hemorrhages
• Optic cupping and atrophy occur later as the edema
resolves
Arteritic Anterior Ischemic Optic Neuropathy
Management
• Laboratory testing:
• Erythrocyte sedimentation rate (ESR)
• ≥ 47 mm/h
• Normal in 13% of GCA patients
• C-reactive protein (CRP)
• ≥ 2.45 mg/dl
• CBC with differential = anemia of chronic inflammation
ESR + CRP 99% sensitivity, 97% specificity for
GCA
Arteritic Anterior Ischemic Optic Neuropathy
Treatment
• Systemic corticosteroids
• Immediate IV steroid therapy
• 2 weeks or until symptoms resolve and ESR, CRP normalize
• Slow taper of oral prednisone for ~ 24 months.
• Temporal artery biopsy (gold standard)
• Once visual loss occurs, it is rarely recovered.
3/29/2016
15
Case Presentation:
• Blowout Fracture
Case Presentation
• Penetrating Ocular Injury
Case Presentation
• Perforating Ocular Injury
3/29/2016
16
Risk Factors for Open Globe Trauma
Take Home Message
• Have a clear pre-determined plan of action
• Be prepared with an emergency kit:
• Litmus strips
• IOP lowering medications
• BP kit
• Thermometer for suspected cellulitis
• Fox shield and tape
• CPR responder pack
• Epinephrine pen
• Calm demeanor in the face of emergency is critical because patients feel
worse and loses confidence if the doctor appears anxious
Take Home Message
• Knowledge of local professionals who can help and know how to refer:
• Ophthalmologist with specialty
• Emergency room
• Internal medicine
• Neurology
• Radiology
• Infectious disease specialist
• Document, document, document
• If it is not in the chart, it was not done
• Appropriate follow up care
• Phone calls to patient as well as specialty doctors will enhance the quality of care
3/29/2016
17
LASIK Emergency - Presentation
• ER physician calls about 29 yo AF post op week #2 after LASIK OU with a 20/20
result OU whose 5 year old child had struck her in the eye with a “piece of metal”
• Vision on presentation: 20/CF at 2’
• Symptoms: significant pain and photophobia
LASIK Emergency – Physical Exam
• Corneal tissue appeared heaped up over visual axis
LASIK Emergency - Management
3/29/2016
18
LASIK Emergency – Follow Up
• Presentation 20/CF • Post reposition, cleaning, smoothing, and epithelial debridement
• 2 Days post op
• UCDVA 20/20
• PROMPT repositioning and smoothing critical to prevent permanent tissue folds
References1. Allingham, R. R., Damji, K. F., Freedman, S. F., Moroi, S. E., Rhee, D. J., & Shields, M. B. (2012). Shields textbook of glaucoma. Lippincott Williams & Wilkins.
2. Gorovoy, I. R., T. C. Porco, R. B., et al "Same-Day Versus Next-Day Repair of Fovea-Threatening Primary Rhegmatogenous Retinal Detachments." Semin Ophthalmol. 21 Aug.
2015: 1-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25081305. Accessed March 01, 2016
3. Harrington JN. Orbital Cellulitis. Medscape Reference: Drugs, Diseases and Procedures. Available at: http://emedicine.medscape. com/article/1217858-overview. Accessed
February 27, 2016
4. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997 Mar;123(3):285-96. Accessed
March 01, 2016
5. Holekamp NM Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. American Journal of
Ophthalmology, vol. 139, pp. 302-310, Feb. 2016
6. http://www.intechopen.com/books/advances-in-ophthalmology/retinal-vascular-occlusions. Accessed March 15, 2016.
7. Kabat A. and Sowka J. Don’t get Burned. Identify products that can cause chemical harm, so you can thwart pain and preclude serious complications. Rev Optom. 2006 April;
143:04
8. Kanski, Jack J, Brad Bowling, Ken K. Nischal, and Andrew Pearson. Clinical Ophthalmology: A Systematic Approach. Edinburgh: Elsevier/Saunders, 2011.
9. Mario Bradvica, Tvrtka Benašić and Maja Vinković (2012). Retinal Vascular Occlusions, Advances in Ophthalmology, Dr Shimon Rumelt (Ed.), InTech, Available from:
10. Midelfart A, Hagen YC, Myhre GB. Tidsskr Nor Laegeforen. 2004 Jan 8; 124(1):49-51.
11. Onofrey, Bruce E.,, Leonid Skorin, Jr., and Nicky R. Holdeman. Ocular Therapeutics Handbook: A Clinical Manual. Third Edition. Philadelphia: Wolters Kluwer Health/Lippincott
Williams & Wilkins, 2011.
12. Potter W. In the Event of an Emergency. Rev Optom. 2013 Aug. Available at: http://www.reviewofoptometry.com/continuing_education/tabviewtest/lessonid/109300/. Accessed
March 07, 2016.
13. Singh, Parul et al. “Ocular Chemical Injuries and Their Management.” Oman Journal of Ophthalmology 6.2 (2013): 83–86. PMC. Web. 20 Mar. 2016.
14. Than T.P. and Hardie E.B. Meds that Don’t Mix with Glaucoma Patients. Rev Optom. 2012 Oct. Available at:
http://www.reviewofoptometry.com/continuing_education/tabviewtest/lessonid/108612#topa. Accessed March 20, 2016
15. Trobe J. D. The Rule of the Pupil Revisited: For Pupil-Involved Third Nerve Palsy and Aneurysm, Is the Diagnostic “Gold Standard” Really a Catheter Angiogram in 2009?. North
America Neuro-Ophthalmology Society, 2009, PP 107-110, March 02, 2016
16. Varma D.D., Cugati S., et al. A Review of Central Retinal Artery Oclusion: Clinical Presentation and Management. Eye e (2013) 27, 688–697. Available at:
http://www.nature.com/eye/journal/v27/n6/pdf/eye201325a.pdf. Accessed March 06, 2016.